My watch list
my.chemeurope.com  

my.chemeurope.com

With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

Pain Therapeutics, Inc



Pain Therapeutics, Inc. is a biopharmaceutical company, that engages in the research and development of drugs for use in pain management, primarily in the area of opioid painkillers in the United States. Its Phase III clinical trial products include Remoxy, which is an anti-abuse version of long-acting oxycodone; and Oxytrex, which is an opioid painkiller for the treatment of chronic pain. The company has a strategic alliance with King Pharmaceuticals, Inc. for the development and commericalization of Remoxy and other abuse-resistant opioid painkillers. Pain Therapeuctics was founded in 1998 and is based in South San Francisco, California.

Remi Barbier is the founder, Chairman, Chief Executive Officer and President.

Chris Ohms is an avid cyclist and a director at Pain Therapeutics.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pain_Therapeutics,_Inc". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE